Volume 31, Number 11—November 2025
Synopsis
Trichosporon austroamericanum Infections among Hospitalized Patients, France, 2022–2024
Figure 4
![Single-nucleotide polymorphism (SNP) map and phylogenetic analysis of mitogenomes from investigation of Trichosporon austroamericanum infections among hospitalized patients, France, 2022–2024. A) SNP map of mitochondrial genomes from T. austroamericanum isolates. The SNP alignment highlights 3 key positions in the mitochondrial genome (at positions 22240 in the cox3 gene, 31837 in the apocytochrome b gene, and 39897 in the trnL [tRNA-Leu] gene). B) Phylogenetic placement of clinical isolates (red font), the environmental strain (blue font), and strains from the National Reference Centre for Invasive Mycoses and Antifungals at Institut Pasteur (https://www.pasteur.fr). Scale bar indicates nucleotide substitutions per site.](/eid/images/25-0503-F4.jpg)
Figure 4. Single-nucleotide polymorphism (SNP) map and phylogenetic analysis of mitogenomes from investigation of Trichosporon austroamericanum infections among hospitalized patients, France, 2022–2024. A) SNP map of mitochondrial genomes from T. austroamericanum isolates. The SNP alignment highlights 3 key positions in the mitochondrial genome (at positions 22240 in the cox3 gene, 31837 in the apocytochrome b gene, and 39897 in the trnL [tRNA-Leu] gene). B) Phylogenetic placement of clinical isolates (red font), the environmental strain (blue font), and strains from the National Reference Centre for Invasive Mycoses and Antifungals at Institut Pasteur (https://www.pasteur.fr). Scale bar indicates nucleotide substitutions per site.
Page created: September 18, 2025
Page updated: December 10, 2025
Page reviewed: December 10, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.